Milrinone has 3 known drug interactions based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Anagrelide, Anagrelide Hydrochloride. Patients taking Milrinone should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Contraindicated
- 1
- Major
- 1
Contraindicated (1)
- Milrinone + Anagrelide— Avoid use; both are PDE3 inhibitors with exacerbation of inotropic effects.
Major (1)
- Milrinone + Anagrelide Hydrochloride— Avoid use due to exacerbation of inotropic effects as PDE3 inhibitor.